IceCure Medical Ltd (ICCM) Stock Ticker
Market factors today
Unlock the full ICCM picture
About IceCure Medical Ltd
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.
ICCM stock facts
| Ticker symbol | ICCM |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Medical - Devices |
| Market cap | $3.9M |
| CEO | Eyal Shamir |
| Employees | 68 |
| Headquarters | Caesarea, HA, IL |
| IPO date | 2021-08-26 |
| Website | www.icecure-medical.com |
What you can see for ICCM on Tickr
Live ICCM price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the ICCM report.
Rankings
FAQ
What is the ticker symbol for IceCure Medical Ltd?
The ticker symbol for IceCure Medical Ltd is ICCM, listed on the NASDAQ Capital Market.
What is ICCM?
Headquartered in Caesarea, Israel, and founded in 2006, IceCure Medical Ltd is a medical device enterprise dedicated to inventing, refining, and marketing innovative solutions for treating human tumors through cryoablation, a freezing process. Their primary offering, the ProSense system, provides a specialized cryoablation therapy specifically for breast tumors.